Viewing StudyNCT04842513

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-06 @ 4:02 PM
Last Modification Date: 2024-10-26 @ 2:02 PM
Study NCT ID: NCT04842513
Status: RECRUITING
Last Update Posted: 2023-12-05
First Post: 2021-03-01
Brief Title: Multi Peptide Vaccination With XS15 in Addition to Standard Postoperative Radiation Therapy and Temozolomide Chemotherapy in Newly Diagnosed Glioblastoma
Sponsor: University Hospital Tuebingen
Organization: University Hospital Tuebingen
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Glioblastoma Multiforme of Brain
Keywords: